Biohaven Ltd. (BHVN) vs Vir Biotechnology, Inc. (VIR)
- Biohaven Ltd. BHVN 10.78 −5.69%
- Vir Biotechnology, Inc. VIR 9.96 −4.87%
Biohaven Ltd. and Vir Biotechnology, Inc. are both Biotechnology companies. Biohaven Ltd. and Vir Biotechnology, Inc. are of similar size ($1.8B and $1.7B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,495.9% against 425.2%. Biohaven Ltd. has the higher net margin (0.00% vs −83.0%) and the lower return on invested capital (−9,245.4% vs −39.1%). Across the 17 metrics below, Vir Biotechnology, Inc. leads on 10 and Biohaven Ltd. on 7.
Valuation
Profitability
| Metric | BHVN | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (92.40%) | 0.00% |
| Net margin | 0.00% | (83.00%) | 0.00% |
| Free cash flow margin | 0.00% | (67.17%) | 0.00% |
| Return on equity | (799.46%) | (26.08%) | (56.36%) |
| Return on assets | (127.41%) | (20.91%) | (48.04%) |
| Return on invested capital | (9,245.36%) | (39.10%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack